title: Cyclosporine levels in the early posttransplant period: predictive of chronic rejection in liver transplantation?
authors.affiliation: University of Cambridge Clinical School, UK.
authors.forename: A S
authors.initials: AS
authors.lastname: Soin
authors.forename: A
authors.initials: A
authors.lastname: Rasmussen
authors.forename: N V
authors.initials: NV
authors.lastname: Jamieson
authors.forename: Y
authors.initials: Y
authors.lastname: Tokat
authors.forename: C J
authors.initials: CJ
authors.lastname: Watson
authors.forename: P J
authors.initials: PJ
authors.lastname: Friend
authors.forename: D G
authors.initials: DG
authors.lastname: Wight
authors.forename: R Y
authors.initials: RY
authors.lastname: Calne
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000097:blood* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006084:Graft Rejection / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D015994:Incidence; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011237:Predictive Value of Tests; D012307:Risk Factors; D013256:Steroids / Q000627:therapeutic use
chemical_list: D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D013256:Steroids; D016572:Cyclosporine; D001379:Azathioprine